AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
28.46
-0.58 (-2.00%)
At close: Apr 28, 2026, 4:00 PM EDT
28.48
+0.02 (0.07%)
After-hours: Apr 28, 2026, 4:02 PM EDT
AtriCure Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AtriCure stock have an average target of 51.17, with a low estimate of 45 and a high estimate of 55. The average target predicts an increase of 79.80% from the current stock price of 28.46.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 18, 2026.
Analyst Ratings
The average analyst rating for AtriCure stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 5 | 4 | 4 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $64 → $53 | Strong Buy | Maintains | $64 → $53 | +86.23% | Feb 18, 2026 |
| UBS | UBS | Strong Buy Maintains $60 → $55 | Strong Buy | Maintains | $60 → $55 | +93.25% | Feb 18, 2026 |
| Citizens | Citizens | Buy Maintains $60 → $52 | Buy | Maintains | $60 → $52 | +82.71% | Feb 18, 2026 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 18, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $54 | Strong Buy | Reiterates | $54 | +89.74% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
616.13M
from 534.53M
Increased by 15.27%
Revenue Next Year
691.39M
from 616.13M
Increased by 12.21%
EPS This Year
0.07
from -0.24
EPS Next Year
0.36
from 0.07
Increased by 432.81%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 640.5M | 718.1M | |||
| Avg | 616.1M | 691.4M | |||
| Low | 589.1M | 654.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.8% | 16.6% | |||
| Avg | 15.3% | 12.2% | |||
| Low | 10.2% | 6.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.14 | 0.64 | |||
| Avg | 0.07 | 0.36 | |||
| Low | - | 0.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 855.6% | |||
| Avg | - | 432.8% | |||
| Low | - | 236.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.